125 related articles for article (PubMed ID: 9692670)
1. Generic warfarin: implications for patient care--another view.
Meyer M; Chan K; Bolton S
Pharmacotherapy; 1998; 18(4):884-6; discussion 887-9. PubMed ID: 9692670
[No Abstract] [Full Text] [Related]
2. Generic warfarin: implications for patient care.
Wittkowsky AK
Pharmacotherapy; 1997; 17(4):640-3. PubMed ID: 9250543
[No Abstract] [Full Text] [Related]
3. Reflections on generic warfarin.
Haines ST
Am J Health Syst Pharm; 1998 Apr; 55(7):729-33. PubMed ID: 9558427
[No Abstract] [Full Text] [Related]
4. In favor of Coumadin over generic warfarin.
Benson SR; Vance-Bryan K
Am J Health Syst Pharm; 1998 Apr; 55(7):727-9. PubMed ID: 9558426
[No Abstract] [Full Text] [Related]
5. Generic substitution: issues for problematic drugs.
Henderson JD; Esham RH
South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
[TBL] [Abstract][Full Text] [Related]
6. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
[TBL] [Abstract][Full Text] [Related]
7. Does generic warfarin measure up?
Check W
CAP Today; 1999 Jan; 13(1):1, 30, 34-7. PubMed ID: 10339317
[No Abstract] [Full Text] [Related]
8. Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?
DeCara JM; Croze S; Falk RH
Chest; 1998 Feb; 113(2):261-3. PubMed ID: 9498932
[No Abstract] [Full Text] [Related]
9. Substituting warfarin products: what's the source of the problem?
Haines ST
Ann Pharmacother; 2011 Jun; 45(6):807-9. PubMed ID: 21666090
[TBL] [Abstract][Full Text] [Related]
10. Epistaxis associated with elevation of INR in a patient switched to generic warfarin--another view.
Meibohm B; Zhang W; Beierle I; Meyer MC
Pharmacotherapy; 2000 Jul; 20(7):866-9; discussion 869-71. PubMed ID: 10907982
[No Abstract] [Full Text] [Related]
11. [Generic drugs, bioavailability, and bioequivalence].
Palma-Aguirre JA
Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395
[No Abstract] [Full Text] [Related]
12. Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence.
Zhang X; Wen H; Fan J; Vince B; Li T; Gao W; Kinjo M; Brown J; Sun W; Jiang W; Lionberger R
CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):523-531. PubMed ID: 28379643
[TBL] [Abstract][Full Text] [Related]
13. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Bongiorno RA; Nutescu EA
Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of bioequivalence and interchangeability of narrow therapeutic range drugs: focus on warfarins.
Vercaigne LM; Zhanel GG
J Pharm Pharm Sci; 1998; 1(3):92-4. PubMed ID: 10948395
[No Abstract] [Full Text] [Related]
15. Observational cohort study of switching warfarin sodium products in a managed care organization.
Swenson CN; Fundak G
Am J Health Syst Pharm; 2000 Mar; 57(5):452-5. PubMed ID: 10711525
[TBL] [Abstract][Full Text] [Related]
16. Comments on the note for guidance on bioavailability and bioequivalence in the European Union.
Calvo G
Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721
[No Abstract] [Full Text] [Related]
17. Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis.
Leclerc J; Blais C; Rochette L; Hamel D; Guénette L; Poirier P
Am J Cardiovasc Drugs; 2019 Jun; 19(3):287-297. PubMed ID: 30471054
[TBL] [Abstract][Full Text] [Related]
18. Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs.
Hottinger M; Liang BA
Am J Law Med; 2012; 38(4):667-89. PubMed ID: 23356099
[TBL] [Abstract][Full Text] [Related]
19. Comment on Disintegration/dissolution profiles of copies of Fosamax (alendronate).
Bolaños Díaz R
Curr Med Res Opin; 2004 Jul; 20(7):1035-6; author reply 1036-7. PubMed ID: 15265248
[No Abstract] [Full Text] [Related]
20. Skin necrosis induced by generic enoxaparin.
Gucalp A; Parameswaran R; Lacouture M; Abou-Alfa G; Soff G
Am J Hematol; 2013 Apr; 88(4):339. PubMed ID: 23450519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
